FDA Classifies High Throughput Genomic Sequence Analyzer for Clinical Use into Class II with Special Controls

Summary

The FDA is classifying the high throughput genomic sequence analyzer for clinical use into class II with special controls to ensure a reasonable assurance of safety and effectiveness, following a classification order that outlines the special controls applicable to the device.